Navigation Links
A complete view of complexity in science and society in a new authoritative reference work
Date:7/10/2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...of debate. A high-profile study a few years ago su...arbon from trees and leaves, evidence for a very c...ystems. , But new research from the University o...Algae provide a much richer diet for fish and othe...is week in the Proceedings of the National Academ...
(Date:11/23/2009)...vidence that the "synergistic" effect of early-lif...on and indoor endotoxin causes more harm to develo... , Environmental health scientists at the Univer...hown that children exposed to both high levels of ...ing early life are six times more likely to experi...
(Date:11/23/2009)...of day matters to forest trees dealing with drough... team led by Professor Malcolm Campbell, Universit...arch and colleagues in the department of cell and ...pitalizing on their previous work to decode the ge...d how poplar trees use their 45,000 genes to respo...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Atlantic Pharmaceuticals Inc Announces Completion of Successful Pre IND Meeting with FDA for Abuse Deterrent Narcotic 49728 1Atlantic Pharmaceuticals Inc Announces Completion of Successful Pre IND Meeting with FDA for Abuse Deterrent Narcotic 49728 2Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 1Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 2Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 3ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 1ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 2ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 3
...ist has discovered key appetite control cells in t...ased hunger and potentially weight-gain as we grow...oendocrinologist with Monash University,s Departme..., Dr Andrews found that appetite-suppressing cell...aid the degeneration is more significant following...
... many men during their fight against prostate canc...searchers have found. The findings were published ...edings of the National Academy of Sciences . , Th...edeviled patients for decades. Hormone therapy, a ...ncer, generally keeps the cancer at bay for a year...
...s(TM) Wireless Data Communications Link School ..., WALL, N.J., Aug. 20 BIO-key International,Inc....sed biometric,identification and wireless public s...of MobileSRO(TM) and MobileCampus(TM), silent, sec...-12 schools and higher,education, respectively., ...
Other Biology News:Killer carbs -- Monash scientist finds the key to overeating as we age 2Why a common treatment for prostate cancer ultimately fails 2Why a common treatment for prostate cancer ultimately fails 3Why a common treatment for prostate cancer ultimately fails 4BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3
(Date:11/25/2009)..., ,, BOCARATON,Fla.,Nov.25/PRNewswire/--For...yLogicMD.Thenation,slargestandfastestgrowingnetwor...llysupervised bioidenticalhormones has grownthenum...-from21to36physicians -andisinprogresstoaddmorephy...endofthisyear. ,, Inthepastyear ,BodyLogicMDhas...
(Date:11/25/2009)..., SANDIEGO,Nov.25/PRNewswire-FirstCall/--ArdeaBio...yD.Quart,Pharm.D.,presidentandchiefexecutiveoffice...Conference. , ,Presentationdetailsareasfollows:,...esday,December1,2009,Time:2:00p.m.EasternTime,Loca...ef=,http://www.corporate-ir.net/ireye/,target=,_b...
(Date:11/24/2009)... The New York investment bank ...SX:NEU) has agreed an AU$6.7 mil convertible note ...or. The private placement was arranged by KTA Capi...sor. , New York (PRWEB) N...tment bank KTA Capital, LLC ("KTA Capital&quo...
(Date:11/24/2009)..., ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-Al...heNASDAQOMXconferenceonTuesday,December1stat1:45PM...nvialiveaudiobroadcastovertheInternetavailableat ...erscanclickthe"Webcast"icontoaccessthisfile. ,,...eScienceandHighTechnologycompany.Itschemicalandbio...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
.... 28 Beckman,Coulter, Inc. (NYSE: BEC ), announc...ents with Adventist Health to provide a broad rang...t approximately $36 million over,six years. Advent... care,system with facilities in California, Hawaii...scom.com/cgi-bin/prnh/20031202/BECLOGO ), Under t...
...um Drives 71% Year-Over-Year Growth in Core ... Calif., Oct. 28 Cepheid (Nasdaq:,CPHD) today rep....9,million, an increase of 24% over the third quar...$(0.11) per share, which compares to revenue of $3....09) per share, in the third,quarter of fiscal 200...
...ovavax, Inc.,(Nasdaq: NVAX ) a clinical-stage vac...vi, President and Chief Executive Officer, will be... am. (PT) on October 30, 2008 at the,Palace Hotel ...vide an,overview of the company,s strategy, resear...esentation can be accessed via the Company website...
Other Biology Technology:Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care 2Cepheid Reports Third Quarter Revenue of $44.9 Million 2Cepheid Reports Third Quarter Revenue of $44.9 Million 3Cepheid Reports Third Quarter Revenue of $44.9 Million 4Cepheid Reports Third Quarter Revenue of $44.9 Million 5Cepheid Reports Third Quarter Revenue of $44.9 Million 6Cepheid Reports Third Quarter Revenue of $44.9 Million 7Cepheid Reports Third Quarter Revenue of $44.9 Million 8Cepheid Reports Third Quarter Revenue of $44.9 Million 9Cepheid Reports Third Quarter Revenue of $44.9 Million 10Cepheid Reports Third Quarter Revenue of $44.9 Million 11Cepheid Reports Third Quarter Revenue of $44.9 Million 12Cepheid Reports Third Quarter Revenue of $44.9 Million 13
Mouse Anti-Human CD182 (CXCR2) Monoclonal Antibody, Unconjugated, Clone 5E8/CXCR2 from BioLegend
Rabbit Anti-Human Purinergic Receptor P2Y12 Polyclonal Antibody, Unconjugated from IMGENEX
Goat Anti-Human AGAP1 / Centaurin, gamma 2 Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Human CLAN Polyclonal Antibody, Unconjugated from IMGENEX
Biology Products: